This compound is a pharmaceutical impurity reference standard, specifically a derivative of agomelatine. It is characterized by an amide, an aromatic ring, and an ether functional group, and is used in quality control and analytical testing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 178677-39-9
Remibrutinib
pharmaceutical raw material
Ticagrelor sulphone
pharmaceutical raw material
(RS)-tegafur
pharmaceutical raw material
(1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)acetic acid--4-(((2-amino-3,5-dibromophenyl)methyl)amino)cyclohexan-1-ol (1/1)
pharmaceutical raw material
Ethyl2-(3,4-Dihydro-7-Methoxy-1(2H)-naphthalenylidene)acetate
pharmaceutical intermediate
Agomelatine Acetic Acid
pharmaceutical intermediate
N-[(2E)-2-(7-methoxy-3,4-dihydro-2H-naphthalen-1-ylidene)ethyl]acetamide
WYDPNFMLFHAFHV-MDWZMJQESA-N
CC(=O)NC/C=C/1\CCCC2=C1C=C(C=C2)OC